| Prev Close | 5.64 |
| Open | 5.65 |
| Day Low/High | 5.50 / 5.69 |
| 52 Wk Low/High | 5.27 / 14.15 |
| Volume | 2.73M |
| Avg Volume | 4.98M |
| Exchange | NASDAQ |
| Shares Outstanding | 223.34M |
| Market Cap | 1.23B |
| EPS | -9.10 |
| P/E Ratio | N/A |
| Div & Yield | N.A. (N.A) |
While more than half the states in the U.S. have passed time limits on opioid prescription as a way to battle the epidemic, the AMA says that should be left up to the doctor and patient.
Investors in Endo International plc saw new options begin trading today, for the May 25th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new May 25th contracts and identified one put and one call contract of particular interest.
President Trump made a long-awaited announcement of his administration's opioid plan in a New Hampshire speech that was part policy roll out and part political rally.
A study published by the Journal of the American Medical Association shows OTC drugs were more effective in cutting pain for chronic back pain and osteoarthritis hip and knee patients than opioids.
After months of inaction by the federal government on the crisis regarding opioid abuse, Attorney General Jeff Sessions announced the creation of a task force charged with looking at how drug makers and distributors operate.
Investors in Endo International plc saw new options begin trading today, for the April 6th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new April 6th contracts and identified one put and one call contract of particular interest.
As lawsuits tied to the opioid crisis keep piling up, Purdue Pharma is discontinuing direct sales calls to doctors. Will other opioid makers follow suit?
Investors in Endo International plc saw new options become available today, for the March 23rd expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new March 23rd contracts and identified one put and one call contract of particular interest.
New York City sues Purdue Pharma, Teva Pharmaceutical, Allergan, Johnson and Johnson, Endo International, McKesson, AmerisourceBergen and Cardinal Health over how opioids have devastated the city and its services.
A group of hospital systems led by Intermountain Healthcare said Jan. 18 they are planning to form a not-for-profit generic drug firm to address drug shortages and high costs.
As opioid crisis becomes more deadly, public hearings put the pain killers front and center. But in bitterly divided Washington one meeting is more about chopping Medicaid.
The crisis could seemingly turn a number of companies on their heads much in the way that big tobacco suits of the late 1990s forever changed the tobacco industry.
Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Endo International, Plc.
Pomerantz LLP announces that a class action lawsuit has been filed against Endo International plc ("Endo" or the "Company") (NASDAQ:ENDP) and certain of its officers.
Investors in Endo International plc saw new options begin trading this week, for the February 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ENDP options chain for the new February 2018 contracts and identified one put and one call contract of particular interest.
Investors in Endo International plc saw new options become available this week, for the July 2018 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.
Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Endo International, Plc.
